CLINICAL_TRIALS
trial_result
· 2020-06-04
Clinical Trial Update: The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine [Phase 4]
Summary
Phase 4 trial update exploring potential dependence and withdrawal symptoms associated with valbenazine in tardive dyskinesia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurocrine Biosciences | Conditions: Tardive Dyskinesia (TD) | Phase 4 | Status: COMPLETED | Results posted: 2020-06-04